Tatva Chintan Pharma Chem Ltd Q3FY24; 70% fall in Profits

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals

Financial Results:

Tatva Chintan Pharma Chem Ltd reported Revenues for Q3FY24 of ₹84.21 Crores down from ₹120.61 Crore year on year, a fall of 30.18%.

Total Expenses for Q3FY24 of ₹80.17 Crores down from ₹107.46 Crores year on year, a fall of 25.4%.

Consolidated Net Profit of ₹3.46 Crores down 70.22% from ₹11.62 Crores in the same quarter of the previous year.

The Earnings per Share is ₹1.48, down 71.76% from ₹5.24 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.